tiprankstipranks
Laboratorios Farmaceuticos Rovi, SA (ES:ROVI)
BME:ROVI
Spanish Market
ROVI
Laboratorios Farmaceuticos Rovi
RESEARCH TOOLSreports

Laboratorios Farmaceuticos Rovi (ROVI) Stock News & Sentiment

39 Followers
ROVI’s Earnings Call: Mixed Sentiment Amid Growth and Challenges
Premium
Company Announcements
ROVI’s Earnings Call: Mixed Sentiment Amid Growth and Challenges
9M ago
Rovi Approves Key Resolutions and Re-elects CEO at Shareholders’ Meeting
Premium
Company Announcements
Rovi Approves Key Resolutions and Re-elects CEO at Shareholders’ Meeting
10M ago
ROVI Secures €36.3 Million for Innovative Drug Development Project
Premium
Company Announcements
ROVI Secures €36.3 Million for Innovative Drug Development Project
11M ago
ROVI Announces Upcoming Shareholders’ Meeting and Dividend Proposal
Premium
Company Announcements
ROVI Announces Upcoming Shareholders’ Meeting and Dividend Proposal
11M ago
ROVI Reports First-Quarter 2025 Liquidity Operations
Premium
Company Announcements
ROVI Reports First-Quarter 2025 Liquidity Operations
1y ago
ROVI Unveils Strategic Update for Next Growth Phase
Premium
Company Announcements
ROVI Unveils Strategic Update for Next Growth Phase
1y ago
ROVI Unveils Strategic Update for Growth Phase
Premium
Company Announcements
ROVI Unveils Strategic Update for Growth Phase
1y ago
More ES:ROVI News >

ROVI News on the Web

Jefferies downgrades Laboratorios Farmaceuticos Rovi (0ILL) to a Hold
TipRanks News
Neutral
Assessing Laboratorios Farmaceuticos Rovi (BME:ROVI) Valuation After 2025 Results Dividend Hike And 2026 Guidance
Simply Wall St
Neutral
Kepler Capital Sticks to Its Buy Rating for Laboratorios Farmaceuticos Rovi (0ILL)
TipRanks News
Neutral
Is Laboratorios Farmaceuticos Rovi (BME:ROVI) Using Too Much Debt?
Simply Wall St
Neutral
Laboratorios Farmaceuticos Rovi (0ILL) Receives a Buy from Kepler Capital
TipRanks News
Neutral
Here's What Analysts Are Forecasting For Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI) After Its Third-Quarter Results
Simply Wall St
Neutral
Laboratorios Farmaceuticos Rovi (BME:ROVI) Seems To Use Debt Quite Sensibly
Simply Wall St
Neutral
Investors in Laboratorios Farmaceuticos Rovi (BME:ROVI) have seen notable returns of 100% over the past five years
Simply Wall St
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ES:ROVI’s Media Buzz Sentiment?
Currently, no data Available
What is ES:ROVI’s weekly average amount of articles?
Currently, no data Available
What is ES:ROVI’s News Sentiment?
Currently, no data Available
General Stocks that are Trending in the News
SZYCFSaizeriya Co
0RJIAnheuser Busch InBev SA/NV
ENWEnwave Corp
THXThor Explorations
ZDCZedcor Energy Inc
Showing the stocks with the most bullish news sentiment over the past week